VIM and metastatic malignant neoplasm in the lymph nodes: Moreover, a transcriptomic study comparing HN12, an OSCC cell line derived from lymph node metastasis, to HN4, its non-metastatic equivalent, showed an 87-fold increase in vimentin expression.